NDC 16714-221-12 - Granisetron Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16714-221
- Requested NDC
- 16714-221-12
- Package NDCs from labels
- 16714-221-10, 16714-221-30, 16714-221-12, 16714-221-32, 16714-221-01
- Manufacturer
- Northstar Rx LLC | Orchid Pharma Ltd. | Orchid Healthcare (A Division of Orchid Pharma Ltd)
- Effective date
- 2020-11-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Granisetron Hydrochloride | Northstar Rx LLC | Orchid Pharma Ltd. | Orchid Healthcare (A Division of Orchid Pharma Ltd) | 2020-11-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Granisetron Hydrochloride | Northstar Rx LLC | Orchid Pharma Ltd | Orchid Healthcare (A Division of Orchid Pharma Ltd) | 2020-11-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16714-221-01 | EA - Each | 16714-221 | 42e00df4-5287-41f6-845a-d7a52beee104 | 1 | 2012-07-24 |
| 16714-221-10 | EA - Each | 16714-221 | a9d6a32a-68ff-4e43-a883-783c364bbcb5 | 1 | 2017-04-05 |
| 16714-221-12 | EA - Each | 16714-221 | 796faa2f-aab6-4dba-8a95-d8ff8f04c7ca | 1 | 2017-04-05 |
| 16714-221-30 | EA - Each | 16714-221 | 3d157402-ebab-4884-ba47-d986865965f6 | 1 | 2012-07-24 |
| 16714-221-32 | EA - Each | 16714-221 | 0e95923e-1285-4aab-b3d8-12d16ee5735a | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Eugia US LLC | 783e9d68-2371-4fd4-8d7a-a5e36f8718d0 | 2025-04-24 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisol | GRANISETRON HYDROCHLORIDE | Intra-Sana Laboratories | 2758eb4d-2fe0-4f74-b3f5-b4903009e97c | 2025-03-21 | Warnings, Adverse reactions | 318F6L70J8 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Breckenridge Pharmaceutical, Inc. | df4b6775-4337-41e0-815a-b064d98c3fe1 | 2024-02-29 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e07862df-f324-4575-a1ef-f7e1cbab4c7a | 2024-01-04 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Bionpharma Inc. | 50b713d3-7ca8-465a-aefa-65ddbe17b934 | 2023-12-16 | Warnings, Adverse reactions | ANDA078678 318F6L70J8 |
| Granisetron | GRANISETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | dddc8714-383f-4bc5-a468-ae89dbc802b4 | 2022-11-15 | Warnings, Adverse reactions | 318F6L70J8 |
| 434276c5-ae66-497a-8e30-5d079507dcfa | 7094279a-281a-4e53-ab2a-23fedb8c778a | 2020-11-16 | Warnings, Adverse reactions | 434276c5-ae66-497a-8e30-5d079507dcfa 7094279a-281a-4e53-ab2a-23fedb8c778a | ||
| f02a151c-00f2-4098-9108-16169726ff9f | 03226fdd-8be5-49a7-b63c-62f08e75cd2d | 2020-11-16 | Warnings, Adverse reactions | f02a151c-00f2-4098-9108-16169726ff9f 03226fdd-8be5-49a7-b63c-62f08e75cd2d | ||
| Granisetron hydrochloride | GRANISETRON HYDROCHLORIDE | Natco Pharma Limited | d2be8de3-04fe-4e92-82b4-98d749b89596 | 2019-10-25 | Warnings, Adverse reactions | 318F6L70J8 |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Mylan Institutional LLC | 8d88adba-7f5e-4e97-84b3-6ca8ec98c023 | 2017-08-31 | Warnings, Adverse reactions | 318F6L70J8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.